Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Work
Year: 2014
Type: review
Source: The Lancet
Institutions United States Food and Drug Administration, Helios Hospital Berlin-Buch, German Breast group, NSABP Foundation, Inserm +19 more
Cites: 28
Cited by: 3,898
Related to: 10
FWCI: 30.55
Citation percentile (by year/subfield): 99.88
Subfield: Cancer Research
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed